About
Newleos Therapeutics is a clinical-stage biotechnology company developing oral small molecule therapies targeting novel neuropsychiatric mechanisms to treat mental health conditions such as general anxiety, social anxiety, substance use disorders, and cognitive impairment.
Explore Newleos's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.